Overview
Syndromic microphthalmia-anophthalmia-coloboma (MAC) refers to a group of rare developmental eye disorders in which abnormally small eyes (microphthalmia), absent eyes (anophthalmia), or gaps in ocular structures (coloboma) occur alongside additional systemic abnormalities affecting other organ systems. Unlike isolated MAC, the syndromic forms are characterized by the presence of extra-ocular features, which may include intellectual disability, craniofacial anomalies, cardiac defects, skeletal malformations, brain abnormalities, renal anomalies, and genital malformations, depending on the specific underlying genetic cause. The eye findings result from disrupted development during early embryogenesis, when the optic vesicle and optic fissure fail to form or close properly. The severity of visual impairment ranges from mild visual reduction in cases of small colobomas to complete blindness in bilateral anophthalmia. Numerous genetic causes have been identified for syndromic MAC, including mutations in genes such as SOX2, OTX2, PAX6, FOXE3, BMP4, GDF6, STRA6, ALDH1A3, RAX, VSX2, and others. The inheritance pattern varies depending on the specific syndrome and causative gene, encompassing autosomal dominant, autosomal recessive, and X-linked patterns. Chromosomal abnormalities and copy number variants can also be responsible. Genetic testing, including chromosomal microarray and gene panel or exome sequencing, is recommended for diagnosis and genetic counseling. There is currently no cure for syndromic MAC. Management is multidisciplinary and supportive, involving ophthalmologists, geneticists, and specialists relevant to the associated systemic features. Ocular management may include conformers or prosthetic eyes to promote orbital growth in anophthalmia or severe microphthalmia, surgical correction of coloboma-related complications such as retinal detachment, and low-vision rehabilitation. Associated anomalies such as cardiac defects or renal malformations require appropriate specialist care. Early intervention programs and developmental support are important for children with associated intellectual disability.
Also known as:
Variable
Can be inherited in different ways depending on the underlying gene
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for Syndromic microphthalmia-anophthalmia-coloboma.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Syndromic microphthalmia-anophthalmia-coloboma at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Syndromic microphthalmia-anophthalmia-coloboma.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Syndromic microphthalmia-anophthalmia-coloboma.
Community
No community posts yet. Be the first to share your experience with Syndromic microphthalmia-anophthalmia-coloboma.
Start the conversation →Latest news about Syndromic microphthalmia-anophthalmia-coloboma
No recent news articles for Syndromic microphthalmia-anophthalmia-coloboma.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Syndromic microphthalmia-anophthalmia-coloboma
What is Syndromic microphthalmia-anophthalmia-coloboma?
Syndromic microphthalmia-anophthalmia-coloboma (MAC) refers to a group of rare developmental eye disorders in which abnormally small eyes (microphthalmia), absent eyes (anophthalmia), or gaps in ocular structures (coloboma) occur alongside additional systemic abnormalities affecting other organ systems. Unlike isolated MAC, the syndromic forms are characterized by the presence of extra-ocular features, which may include intellectual disability, craniofacial anomalies, cardiac defects, skeletal malformations, brain abnormalities, renal anomalies, and genital malformations, depending on the spec
At what age does Syndromic microphthalmia-anophthalmia-coloboma typically begin?
Typical onset of Syndromic microphthalmia-anophthalmia-coloboma is neonatal. Age of onset can vary across affected individuals.